Testing effectiveness (Phase 2)Study completedNCT01075100What this trial is testingIxabepilone + Carboplatin Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer US Oncology Research 103
Not applicableActive Not RecruitingNCT06083038What this trial is testingUtilizing Continuous Glucose Monitoring to Characterize and Manage Hyperglycemia in Patients Initiating AlpelisibWho this might be right forMetastatic Breast Cancer HealthPartners Institute 15
Early research (Phase 1)Study completedNCT02897375What this trial is testingPalbociclib With Cisplatin or Carboplatin in Advanced Solid TumorsWho this might be right forSolid NeoplasmStage III Pancreatic CancerStage IIIA Breast Cancer+14 more Emory University 71
Early research (Phase 1)Study completedNCT02719691What this trial is testingPhase I Study of MLN0128 and MLN8237 in Patients With Advanced Solid Tumors and Metastatic Triple-negative Breast CancerWho this might be right forMetastatic Breast CancerSolid Tumors University of Colorado, Denver 47
Testing effectiveness (Phase 2)Ended earlyNCT00597597What this trial is testingPhase II Open-Label Trial of Tarceva in Women With Metastatic, Hormone- and HER2-Negative Breast CancerWho this might be right forMetastatic Breast Cancer Rush University Medical Center 11
Testing effectiveness (Phase 2)Study completedNCT00369655What this trial is testingVEGF Trap in Treating Patients With Metastatic Breast CancerWho this might be right forMetastatic Breast CancerRecurrent Breast CancerStage IV Breast Cancer National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Study completedNCT01271725What this trial is testingLUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment FailuresWho this might be right forBreast Neoplasms Boehringer Ingelheim 74
Testing effectiveness (Phase 2)Study completedNCT00077376What this trial is testingTrastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast CancerWho this might be right forHER2-positive Breast CancerMale Breast CancerRecurrent Breast Cancer+1 more National Cancer Institute (NCI) 61
Testing effectiveness (Phase 2)UnknownNCT05340413What this trial is testingPredicting Olaparib Sensitivity in Patients With Unresectable Locally Advanced/Metastatic HER2-negative Breast Cancer.Who this might be right forHER2-negative Breast CancerMetastatic Breast CancerTriple Negative Breast Cancer SOLTI Breast Cancer Research Group 63
Not applicableNot Yet RecruitingNCT06418139What this trial is testingAssociation of Pembrolizumab Infusion Time and Efficacy in Patients With Non-metastatic Triple-negative Breast Cancer (TNBC) Treated With Neoadjuvant Chemotherapy and ImmunotherapyWho this might be right forNon-Metastatic Breast Carcinoma Assistance Publique - Hôpitaux de Paris 450
Testing effectiveness (Phase 2)WithdrawnNCT00397501What this trial is testingBBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the BrainWho this might be right forBrain and Central Nervous System TumorsBreast CancerCognitive/Functional Effects+2 more OHSU Knight Cancer Institute
Large-scale testing (Phase 3)Looking for participantsNCT06680921What this trial is testingSIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)Who this might be right forLocally Advanced or Metastatic Breast Cancer Jiangsu Simcere Pharmaceutical Co., Ltd. 460
Testing effectiveness (Phase 2)Ended earlyNCT03009058What this trial is testingStudy of IMM 101 in Combination With Standard of Care in Patients With Metastatic or Unresectable CancerWho this might be right forMetastatic Cancer Immodulon Therapeutics Ltd 2
Testing effectiveness (Phase 2)Study completedNCT00193076What this trial is testingCombination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast CancerWho this might be right forBreast Cancer SCRI Development Innovations, LLC 96
Large-scale testing (Phase 3)Active Not RecruitingNCT04191499What this trial is testingA Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Participants With PIK3CA-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 325
Testing effectiveness (Phase 2)Study completedNCT00020332What this trial is testingDocetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer National Cancer Institute (NCI)
Large-scale testing (Phase 3)Active Not RecruitingNCT05306340What this trial is testingA Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)Who this might be right forEstrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer Genentech, Inc. 373
Early research (Phase 1)Active Not RecruitingNCT03988595What this trial is testingExercise Treatment With Standard Therapy for Metastatic Breast CancerWho this might be right forHormone Receptor Positive Metastatic Breast Cancer Memorial Sloan Kettering Cancer Center 54
Post-approval studies (Phase 4)Study completedNCT03583944What this trial is testingEvaluate Safety, Tolerability and Efficacy of Eribulin Mesylate in Treating Adult Females With Locally Advanced or Metastatic Breast CancerWho this might be right forBreast Neoplasms Eisai Inc. 200
Large-scale testing (Phase 3)Study completedNCT01216111What this trial is testingAdjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN)Who this might be right forTriple Negative Breast Cancer Fudan University 647